tenk.fyi

Protalix BioTherapeutics, Inc.

PLXNYSE· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$53.4M

18.5% YoY

Net Income

$2.9M

64.7% YoY

EPS

$0.04

55.6% YoY

Cash

$19.8M

16.4% YoY

FY 2024 · As of 2024-12-31